Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05957380
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B
Dong-A ST Co., Ltd. 120
Large-scale testing (Phase 3)Looking for participantsNCT07743580
What this trial is testing

Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Shionogi 2,000
Not applicableStudy completedNCT04512027
What this trial is testing

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.

Who this might be right for
COVID-19
Composite Interceptive Med Science 10
Testing effectiveness (Phase 2)Ended earlyNCT00267527
What this trial is testing

Evaluate CJC 1295 in HIV Patients With Visceral Obesity

Who this might be right for
ObesityHIV Infections
ConjuChem 120
Large-scale testing (Phase 3)Ended earlyNCT05531149
What this trial is testing

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Who this might be right for
Respiratory InfectionPneumoniaCommunity-acquired Pneumonia+5 more
Biotest 107
Testing effectiveness (Phase 2)Study completedNCT05152849
What this trial is testing

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Axcella Health, Inc 41
Large-scale testing (Phase 3)Study completedNCT02203149
What this trial is testing

Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 399
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00663208
What this trial is testing

A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 167
Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT05992935
What this trial is testing

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Who this might be right for
Norovirus Acute Gastroenteritis
ModernaTX, Inc. 1,407
Not applicableStudy completedNCT07128017
What this trial is testing

Online MBCT for Adjustment Disorder During COVID-19: Efficacy, Mechanisms, and RCT

Who this might be right for
Adjustment DisorderAnxietyDepressive
University of Warsaw 301
Not applicableActive Not RecruitingNCT06231238
What this trial is testing

Balance Acceptance and Commitment Therapy for Long COVID

Who this might be right for
Post-COVID-19 SyndromeLong COVID
King's College London 196
Early research (Phase 1)Study completedNCT05105048
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Who this might be right for
Cytomegalovirus Infection
ModernaTX, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02166047
What this trial is testing

Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 162
Early research (Phase 1)Study completedNCT00000749
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Early research (Phase 1)Study completedNCT02603055
What this trial is testing

A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults

Who this might be right for
Hepatitis E
Jiangsu Province Centers for Disease Control and Prevention 60
Testing effectiveness (Phase 2)Study completedNCT00704184
What this trial is testing

Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 95
Not applicableStudy completedNCT03186235
What this trial is testing

T Regulatory Cells in Hepatitis c Infected Patients

Who this might be right for
Hepatitis C
Assiut University 88
Next Page